KraneShares MSCI All China Health Care Index ETF

Health/Biotechnology

KURE

280 Park Ave,32nd Floor
NEW YORK , NY, 10017

Price

  • $ 15.27 0 % +0.36
    Feb 20, 2025
  • Last Close
  • Net Assets
  • $60.6M
    Feb 28, 2024
  • 52-Week High/Low
  • $20.27 - $12.97

  • Expense Ratio
  • -

Link

Directors

Jun 14, 2023
  • Matthew Stroyman
  • Patrick P. Campo
  • Jonathan Krane
  • John Ferguson

Chief Compliance Officer

  • Michael Quain

Company Name

Holding

More 1.37 %

Documents

Prospectus

link

Annual Reports

link

Returns +
Q

2025 2024 2023 2022 2021 2020
Q1 - -16.9% -4.1% -18.9% 282% 2.8%
Q2 - -5.9% -12.2% 0.4% -6% 34%
Q3 - - -1.5% -24.2% -11.2% 5.1%
Q4 - - -0.6% 20.7% -4% -12%

Returns +
M

J F M A M J J A S O N D
2025 - - - - - - - - - - - -
2024 -19% 10% -6.7% 1.1% -3.4% - - - - - - -

Returns +
A

    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
    0%-18.9%-18.2%-25.5%-2.6%27.3%34.1%0%11.8%6.8%-11.4%

Alpha KURE and S&P 500

KURE and S&P 500

Chart +